HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages FuelCell Energy, Inc. (NASDAQ: FCEL) Investors with Substantial Losses to Contact Firm

FuelCell Energy faces a securities class action alleging it misled investors about manufacturing capacity, production economics and losses tied to its up-to-380MW Fit Energy data-center fuel-cell supply agreement. The company reported a $45.3 million fiscal Q3 2026 net loss, including $17 million of Phase 0 CEPA charges as product costs and overhead exceeded contract pricing; FCEL shares fell nearly 16% in one session. The allegations follow FuelCell's $245.5 million net equity raise from an offering of more than 12 million shares at $21 each, increasing potential investor-loss and litigation risk.

Analysis

The investment issue is not the lawsuit itself; it is whether the disclosed loss-making project economics reveal a repeatable flaw in FCEL's commercialization model. A contract signed before manufacturing scale is proven can convert backlog from a valuation support into a future cash-use obligation, particularly if fixed-cost absorption remains low. The recent equity raise reduces near-term insolvency risk but also increases the probability that shareholders, rather than counterparties, absorb execution losses through additional capital needs or renegotiation.

Near term, litigation headlines are unlikely to be incremental after the initial disclosure, but the November lead-plaintiff date can sustain governance-related overhang and deter marginal buyers. The 1-3 month catalyst is management's next update on production capacity, pricing remedies, cancellation rights, inventory commitments, and cash burn; absence of a credible path to positive unit economics would likely force downward revisions to backlog quality and gross-margin assumptions. Over 6-18 months, the key question is whether data-center power demand creates enough customer urgency for FCEL to reprice contracts or obtain customer-funded capacity expansion; without that leverage, scale may magnify losses rather than cure them.

Consensus may overfocus on the legal claim and underweight contract concentration and working-capital risk. Data-center developers have alternatives for on-site power—including natural-gas generation, reciprocating engines, turbines, batteries paired with grid supply, and other distributed-generation solutions—so FCEL's ability to pass through costs is unproven. A sharp equity decline alone is not a long signal: a higher cash balance does not create value if each incremental MW carries negative gross profit.

This is primarily an FCEL-specific execution event rather than a broad read-through to clean-energy equities. Watch peers and suppliers only for evidence that data-center customers are broadly shifting toward firm on-site power; that would support names with proven manufacturing scale and service economics, not necessarily FCEL.

Key Decisions for Investors

• Maintain/establish a tactical FCEL short on failed rallies into the next operating update, sized modestly given elevated borrow and squeeze risk. Thesis horizon: 1-3 months; cover if management quantifies a funded capacity plan, contract repricing/customer cost sharing, and a credible path to non-negative gross margin on the initial deployment.
• Do not buy FCEL merely on litigation-driven weakness. Upgrade from watchlist only after independently verifiable evidence of production throughput, cash burn per MW, customer deposits or cancellation protections, and revised project-level economics; the missing data are more decision-relevant than the legal deadline.
• For investors seeking the data-center power theme, prefer a relative-value screen rather than a sector-wide renewable-energy short: long established distributed-power beneficiaries such as CMI or CAT against FCEL only after confirming FCEL's borrow availability and beta-adjusted hedge ratio. Reassess if FCEL secures binding customer-funded manufacturing expansion.
• Set alerts for the next earnings release and any CEPA amendment, impairment, inventory write-down, or going-concern/liquidity language. A further material charge or lowered backlog conversion outlook would support extending the short thesis to 6-12 months; disclosure of enforceable price escalation would falsify it.